Photo by schluditsch from unsplash
Here, we describe two patients, previously treated with rituximab, who presented with a protracted SARS-CoV-2 infection with an atypical course. We hypothesized an incomplete viral clearance with persistent pneumonia due… Click to show full abstract
Here, we describe two patients, previously treated with rituximab, who presented with a protracted SARS-CoV-2 infection with an atypical course. We hypothesized an incomplete viral clearance with persistent pneumonia due to an impaired or delayed humoral response. This article is protected by copyright. All rights reserved.
Keywords:
pneumonia rituximab;
cov pneumonia;
rituximab treatment;
sars cov;
protracted sars
Journal Title: Journal of Medical Virology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Journal of Medical Virology
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!